A second chance for promising but unprofitable drugs
We’re constantly looking for innovative ways to improve the Springwise experience, and so we’re now introducing BeeLine Reader, a new technology that helps you read more quickly and efficiently. To learn more about BeeLine Reader, an award-winning startup funded by Intel Capital, see BeeLineReader.com.
One of the unfortunate realities of the pharmaceuticals industry is that promising new drugs are sometimes abandoned simply because they’re not likely to be profitable. Aiming to give such medicines a chance at a new life — not to mention the patients who might benefit from them — Cinderella Therapeutics is a Dutch not-for-profit enterprise that picks up the most promising of such therapies and continues testing them.
Spotted another good idea???
Join our network and earn rewards